Suppr超能文献

载脂蛋白 E 受体 2 和 ABCB1/P-糖蛋白通过 PICALM 共同清除血脑屏障中的淀粉样β肽。

The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.

机构信息

Institute for Pathobiochemistry, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.

Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, United States; Department of Pharmacology and Nutritional Sciences, College of Medicine, University of Kentucky, Lexington, KY, United States.

出版信息

Brain Behav Immun. 2018 Oct;73:21-33. doi: 10.1016/j.bbi.2018.07.017. Epub 2018 Jul 21.

Abstract

The accumulation of neurotoxic amyloid-beta (Aβ) in the brain is a characteristic hallmark of Alzheimer's disease (AD). The blood-brain barrier (BBB) provides a large surface area and has been shown to be an important mediator for removal of brain Aβ. Both, the ABC transporter P-glycoprotein (ABCB1/P-gp) and the receptor low-density lipoprotein receptor-related protein 1 (LRP1) have been implicated to play crucial roles in Aβ efflux from brain. Here, with immunoprecipitation experiments, co-immunostainings and dual inhibition of ABCB1/P-gp and LRP1, we show that both proteins are functionally linked, mediating a concerted transcytosis of Aβ through endothelial cells. Late-onset AD risk factor Phosphatidylinositol binding clathrin assembly protein (PICALM) is associated with both ABCB1/P-gp and LRP1 representing a functional link and guiding both proteins through the brain endothelium. Together, our results give more mechanistic insight on Aβ transport across the BBB and show that the functional interplay of different clearance proteins is needed for the rapid removal of Aβ from the brain.

摘要

脑内神经毒性淀粉样蛋白-β(Aβ)的积累是阿尔茨海默病(AD)的一个特征性标志。血脑屏障(BBB)提供了一个大的表面积,并已被证明是清除脑 Aβ 的重要介质。ABC 转运蛋白 P-糖蛋白(ABCB1/P-gp)和受体低密度脂蛋白受体相关蛋白 1(LRP1)都被认为在 Aβ从脑内流出中发挥关键作用。在这里,通过免疫沉淀实验、共免疫染色和 ABCB1/P-gp 和 LRP1 的双重抑制,我们表明这两种蛋白在功能上是相关的,通过内皮细胞共同转导 Aβ。晚发性 AD 风险因子磷脂酰肌醇结合网格蛋白装配蛋白(PICALM)与 ABCB1/P-gp 和 LRP1 相关,代表了一种功能联系,并引导这两种蛋白穿过脑内皮细胞。总之,我们的研究结果提供了对 Aβ 通过 BBB 转运的更多机制见解,并表明不同清除蛋白的功能相互作用对于 Aβ 从脑内快速清除是必需的。

相似文献

1
The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.
Brain Behav Immun. 2018 Oct;73:21-33. doi: 10.1016/j.bbi.2018.07.017. Epub 2018 Jul 21.
2
Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Fluids Barriers CNS. 2016 Aug 8;13(1):14. doi: 10.1186/s12987-016-0038-x.
3
Differences in amyloid-β clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling.
Neuropharmacology. 2014 Apr;79:668-78. doi: 10.1016/j.neuropharm.2014.01.023. Epub 2014 Jan 24.
4
Magnesium Reduces Blood-Brain Barrier Permeability and Regulates Amyloid-β Transcytosis.
Mol Neurobiol. 2018 Sep;55(9):7118-7131. doi: 10.1007/s12035-018-0896-0. Epub 2018 Jan 30.
6
LRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier.
Neurobiol Aging. 2011 Dec;32(12):2323.e1-11. doi: 10.1016/j.neurobiolaging.2010.05.025. Epub 2010 Jul 13.
7
Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier.
J Clin Invest. 2016 Jan;126(1):123-36. doi: 10.1172/JCI81108. Epub 2015 Nov 30.
8
The Blood-Brain Barrier in Alzheimer's Disease.
Handb Exp Pharmacol. 2022;273:247-266. doi: 10.1007/164_2020_418.
9
Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance.
Nat Neurosci. 2015 Jul;18(7):978-87. doi: 10.1038/nn.4025. Epub 2015 May 25.

引用本文的文献

2
Autophagy in alzheimer disease pathogenesis and its therapeutic values.
Autophagy Rep. 2025 May 8;4(1):2471677. doi: 10.1080/27694127.2025.2471677. eCollection 2025.
4
P-glycoprotein and Alzheimer's Disease: Threats and Opportunities.
ASN Neuro. 2025;17(1):2495632. doi: 10.1080/17590914.2025.2495632. Epub 2025 Apr 23.
5
The blood-brain barrier: a help and a hindrance.
Brain. 2025 Jul 7;148(7):2262-2282. doi: 10.1093/brain/awaf068.
6
Exosomes and non-coding RNAs: bridging the gap in Alzheimer's pathogenesis and therapeutics.
Metab Brain Dis. 2025 Jan 4;40(1):84. doi: 10.1007/s11011-024-01520-7.
8
Pathology of Amyloid-β (Aβ) Peptide Peripheral Clearance in Alzheimer's Disease.
Int J Mol Sci. 2024 Oct 11;25(20):10964. doi: 10.3390/ijms252010964.
9
iPSC-derived blood-brain barrier modeling reveals APOE isoform-dependent interactions with amyloid beta.
Fluids Barriers CNS. 2024 Oct 11;21(1):79. doi: 10.1186/s12987-024-00580-2.
10
Exploring the Frontier: Antisense Long Non-Coding RNAs as Key Regulators in Alzheimer's Disease.
Aging Dis. 2024 Aug 19;16(4):1793-1812. doi: 10.14336/AD.2024.0762.

本文引用的文献

3
Structural studies of amyloid-β peptides: Unlocking the mechanism of aggregation and the associated toxicity.
Biochimie. 2017 Sep;140:176-192. doi: 10.1016/j.biochi.2017.07.011. Epub 2017 Jul 25.
4
Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.
J Neurosci. 2017 Apr 12;37(15):4023-4031. doi: 10.1523/JNEUROSCI.3442-16.2017. Epub 2017 Mar 8.
5
P-gp Protein Expression and Transport Activity in Rodent Seizure Models and Human Epilepsy.
Mol Pharm. 2017 Apr 3;14(4):999-1011. doi: 10.1021/acs.molpharmaceut.6b00770. Epub 2017 Mar 2.
6
Aβ40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway.
J Neurosci. 2016 Feb 10;36(6):1930-41. doi: 10.1523/JNEUROSCI.0350-15.2016.
7
Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier.
J Clin Invest. 2016 Jan;126(1):123-36. doi: 10.1172/JCI81108. Epub 2015 Nov 30.
8
Clearance systems in the brain-implications for Alzheimer disease.
Nat Rev Neurol. 2015 Aug;11(8):457-70. doi: 10.1038/nrneurol.2015.119. Epub 2015 Jul 21.
9
Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance.
Nat Neurosci. 2015 Jul;18(7):978-87. doi: 10.1038/nn.4025. Epub 2015 May 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验